Pender has significant expertise and a proven track record of investing in stressed and distressed credits.

We are seeing an opportunity emerge, as the cycle created by the transition in monetary policy and the squeeze from higher interest rates now favours stressed and distressed credits.

Pender Ventures invests in B2B and health-tech startups at the inflection point between commercialization and scale, primarily in Canada.

We are actively investing out of the Pender Technology Inflection Fund II.

One of Pender’s core areas of expertise is investing in small cap companies. We have developed a circle of competence over more than twenty years of fundamental analysis and deep due diligence in small caps, which has contributed to a strong, long-term track record of performance.

In order to earn attractive fixed income returns, we believe investors need to embrace a process which carefully assesses credit – coverage, seniority and duration – and which takes advantage of a wide arsenal of tools and approaches to enhance returns, as evidenced by our track record. Funds are conservatively managed to preserve capital, and are opportunistic to generate returns.